A Fortune 500 company, in conjunction with IBM Watson Health, conducted an economic evaluation to test whether our flagship digital therapeutic for insomnia, Sleepio, would lower health care costs for their employees.
Individuals who used Sleepio had 28% lower annualized total healthcare costs compared to those who did not use Sleepio — demonstrating $1,677 lower health care costs per employee that used Sleepio.
A peek inside:
Here’s our latest
How a Fortune 50 workforce lowered health care costs by nearly 30% with Daylight®
The new health economic research report by a Johns Hopkins professor shows how the use of a digital therapeutic can…
The impact of good mental health in the financial services industry
Our report presents all the evidence you’ll need to make the business case for investing in employee mental health.
Three lessons from the biggest companies on their approach to mental health
Our benchmark report shows how 35+ of the most innovative companies — representing 2.5 million employees lives — are supporting…
